Up Next
Back to Show
PBS News Hour
Why FDA approval of sickle cell gene therapy is a ‘big deal’
Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale School of Medicine assistant professor Dr. Cece Calhoun and New York Times reporter Gina Kolata to learn more.
Support Provided By
26:45
September 21, 2025 - PBS News Weekend full episode
26:45
September 20, 2025 - PBS News Weekend full episode
57:46
September 19, 2025 - PBS News Hour full episode
57:46
September 18, 2025 - PBS News Hour full episode
57:46
September 17, 2025 - PBS News Hour full episode
57:46
September 16, 2025 - PBS News Hour full episode
56:45
September 15, 2025 - PBS News Hour full episode
26:45
September 14, 2025 - PBS News Weekend full episode
26:45
September 13, 2025 - PBS News Weekend full episode
57:46
September 12, 2025 - PBS News Hour full episode
57:46
September 11, 2025 - PBS News Hour full episode
57:46
September 10, 2025 - PBS News Hour full episode